AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant Genetic Test sale cost 4400 AED
FLRT1 Gene SPG68 FLRT1 Related Genetic Test sale cost 4400 AED FLRT1 Gene SPG68 FLRT1 Related Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
ITPR1 Gene Spinocerebellar Ataxia Type 29 Congenital Nonprogressive Genetic Test sale cost 4400 AED ITPR1 Gene Spinocerebellar Ataxia Type 29 Congenital Nonprogressive Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The AFG3L2 gene plays a crucial role in the development and maintenance of the nervous system. Mutations in this gene are directly linked to Spinocerebellar Ataxia Type 28 (SCA28), a rare, autosomal dominant disorder characterized by progressive ataxia, or loss of full control of bodily movements. Individuals with SCA28 may experience a range of symptoms, including difficulty with coordination and balance, speech impairments, and eye movement abnormalities. Given its genetic basis, identifying carriers or affected individuals early can be pivotal in managing the condition and understanding its progression.

DNA Labs UAE offers a specialized genetic test aimed at detecting mutations in the AFG3L2 gene to diagnose Spinocerebellar Ataxia Type 28. This test is particularly valuable for individuals with a family history of SCA28 or those exhibiting symptoms associated with the condition. By utilizing advanced genetic sequencing technologies, DNA Labs UAE provides accurate and reliable results, which are crucial for making informed decisions about treatment and management strategies.

The cost of the AFG3L2 gene test for Spinocerebellar Ataxia Type 28 at DNA Labs UAE is 4400 AED. Given the complexity of the genetic analysis and the profound impact that the results can have on patients and their families, this test represents a significant step forward in the personalized care and management of genetic disorders.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant Genetic Test

Are you concerned about Spinocerebellar Ataxia Type 28 (SCA28)? DNA Labs UAE offers a comprehensive genetic test for the AFG3L2 gene, which is associated with this neurodegenerative disorder.

Test Details

The AFG3L2 gene is linked to SCA28, a condition characterized by neurodegeneration. SCA28 is an autosomal dominant disorder, meaning that individuals with a mutation in one copy of the AFG3L2 gene will develop the condition.

Our Next-Generation Sequencing (NGS) Genetic Test utilizes advanced sequencing technologies to analyze multiple genes simultaneously. By examining the AFG3L2 gene, our test can identify any genetic mutations or variations that may be causing or predisposing an individual to SCA28.

Components and Price

The cost of the AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant Genetic Test is AED 4400.0. The test requires a blood sample for analysis.

Report Delivery and Method

Once the sample is received, the report will be delivered within 3 to 4 weeks. Our NGS Technology ensures accurate and efficient analysis of the AFG3L2 gene.

Test Type and Doctor

The AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant Genetic Test falls under the category of Neurological Disorders. It is recommended to consult with a Neurologist for this test.

Test Department and Pre Test Information

The test is conducted in our Genetics department. Before undergoing the AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by SCA28.

Conclusion

By opting for the AFG3L2 Gene Spinocerebellar Ataxia Type 28 Autosomal Dominant Genetic Test, individuals and their families can gain valuable insights into their genetic makeup. This information can aid in accurate diagnosis, genetic counseling, and potentially explore treatment options for SCA28.

Test Name AFG3L2 Gene Spinocerebellar ataxia type 28 autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for AFG3L2 Gene Spinocerebellar ataxia type 28, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with AFG3L2 Gene Spinocerebellar ataxia type 28, autosomal dominant
Test Details

The AFG3L2 gene is associated with a neurodegenerative disorder called Spinocerebellar Ataxia Type 28 (SCA28). SCA28 is an autosomal dominant disorder, meaning that individuals with a mutation in one copy of the AFG3L2 gene will develop the condition.

NGS Genetic Test refers to Next-Generation Sequencing Genetic Testing. This type of genetic testing uses advanced sequencing technologies to analyze multiple genes simultaneously and identify genetic mutations or variations that may be associated with a particular disorder, in this case, SCA28.

By performing an NGS Genetic Test for the AFG3L2 gene, healthcare professionals can identify any genetic mutations or variations in this gene that may be causing or predisposing an individual to SCA28. This information can be used for accurate diagnosis, genetic counseling, and potential treatment options for affected individuals and their families.

SKU: TEST-2070 Category:

Related products